. Alternatively, the ability of bHLH tor cells in a roughly conserved histogenic order: ganfactors to promote the differentiation of specific cell glion cells and cones are born first, while rods and Mü ller types may depend, in part, upon the cellular context in glia are born last (reviewed in Cepko et al., 1996) . This which they are functioning. Since retinal progenitors fidelity of birth order across divergent species suggests have been proposed to change over developmental time that control of retinal cell differentiation is a highly reguin their competence to generate subtypes of retinal neulated process.
rons ( pressed, and XNeuroD, which promotes differentiation 2A). To confirm that GSK3␤ can inhibit XNeuroD function and determine whether it also inhibits Xath5 function, of the later-born, amacrine cell type (Kanekar et Figure 2H ), ure 1). This raises the possibility that the function of and this was not inhibited by co-injection of GSK3␤ XNeuroD, but not Xath5, is inhibited at early stages of mRNA (0/48 embryos; Figure 2I ). Thus, XNeuroD (S→A) is retinal neurogenesis, thus preventing XNeuroD from both active in promoting neuronal differentiation and promoting the differentiation of the earliest born cell insensitive to the effects of GSK3␤ in the neural plate. types. To explore this possibility, we have considered the serine-threonine kinase GSK3␤ as a candidate regu- Figure  3A ; p Ͻ 0.003). 63% of labeled cells adopted ganglion cell fates at the expense of later-born cell types; this 3-fold increase was similar to that observed in retinal progenitors in Xath5-injected embryos (Kanekar et al., 1997). Co-injection of higher doses of dnGSK3␤ mRNA (50 pg) with XNeuroD (10pg) mRNA had an even more dramatic effect, causing 87.6% Ϯ 4.3% of labeled cells within the retina to differentiate as retinal ganglion cells (n ϭ 687 cells from 13 embryos). Thus, endogenous GSK3␤ in the developing retina appears to inhibit the ability of ectopically expressed XNeuroD to promote retinal ganglion cell differentiation. This effect is not observed with all bHLH factors, since dnGSK3␤ did not alter the ability of ectopically expressed Math5 to promote bipolar cell differentiation (data not shown; Brown et al., 1998). Furthermore, retinal cells derived from blastomeres co-injected with GSK3␤ and Xath5 mRNAs retained their bias toward ganglion fates (data not shown).
To determine whether GSK3␤ modulates the activity of endogenous bHLH factors during retinal development, we injected increasing amounts dnGSK3␤ mRNA and assayed for effects on retinal cell fate. Injection of low amounts of dnGSK3␤ mRNA (10 pg) caused a slight but significant increase in the representation of retinal ganglion cells (RGCs; 23.5% Ϯ 1.5%), compared to GFP controls (18.2% Ϯ 0.7%) ( Figure 3B ). With increasing doses of dnGSK3␤ mRNA, there was an increased shift toward the RGC fate ( Figure 3B ) (32.7% Ϯ 3.8% RGCs at early stages of retinal development. To test this, we mutated SPPLSI to SPPLSV (mNeuroD [I→V] ; Figure 5A ), which is identical to the GSK3␤ consensus phosphorylation sequence found in XNeuroD. When mNeuroD (I→V) was overexpressed by 16-cell RNA injection, only 22% of labeled retinal neurons adopted the ganglion cell fate. Instead, there was a significant increase in amacrine cell differentiation (19.7% Ϯ 0.7%), compared to GFP controls (10.2% Ϯ 0.5%). This is very similar to the effect observed with overexpression of XNeuroD, which results in 21% of labeled cells adopting the amacrine cell fate ( Figure 1A ). These data are confirmation of our model that the activity of bHLH factors in the retina can be regulated through this GSK3␤ consensus phosphorylation sequence. 
GSK3␤ (SPPLSI). This site was mutated to SPPLSV in mNeuroD (I→V) .
We examined clone size in embryos injected with GFP ). These data demonstrate that the ability of Xath5 to promote the differentiation of specific retinal neuron types is dependent less upon inherent retinal subtype-specific information and more upon the cellular context in which it is active. Figure 7C ). This result indicates that release from inhibition at early stages allows Xash1 to promote early, rather than late, cell fates as well. Similar results were obtained with Drosophila scute, which also promotes bipolar differentiation when overexpressed in the Xenopus retina, but early-born cell types when coexpressed with dnGSK3␤ (data not shown). Our results demonstrate that the activities of additional bHLH factors can be altered by inhibition of GSK3␤ in the retina and are consistent with endogenous GSK3␤, serving to regulate the activity of multiple factors that control the differentiation of later-born cell types. Furthermore, these findings demonstrate that bHLH factors from species other than Xenopus can be regulated by GSK3␤.
The Function of Other Late-Acting bHLH Factors

Xath5 and XNeuroD Are Independently Regulated during Retinogenesis
We have shown that the late-acting factors XNeuroD, Mash1, and Xash1 are sensitive to inhibition by GSK3␤ in retinal progenitors, while the early-acting factor Xath5 is not. However, the genesis of early-born neurons is also a coordinated process that is subject to control by negative regulatory pathways. Anti-tyrosine hydroxylase staining was performed, as previously de-CCACCCCTTGCTGTTAACGGGAACTTTAC and ND/GSKMUT-3Ј scribed (Huang and Moody, 1998). AGCAAGGGGTGGGGCCAGGGGACCATCG. The PCR product was cloned into the pCS2ϩ vector using EcoRI and XbaI. A GSK3␤-sensitive form of mNeuroD (mNeuroD [I→V] ) was generated by chang
